Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1997-5-19
pubmed:abstractText
The costimulatory signal provided to T cells through CD28/CTLA-4 interactions is required for in vivo Th cell effector function associated with cytokine production. However, it is uncertain whether the two well-characterized ligands for these molecules, B7-1 and B7-2, differentially influence the consequent development of a type 1 or a type 2 primary response. We have examined the in vivo effects of blocking B7-1 and/or B7-2 ligand interactions on the type 2 mucosal immune response that follows oral infection of mice with the nematode parasite, Heligmosomoides polygyrus. Administration of the combination of anti-B7-1 and anti-B7-2 Abs inhibited H. polygyrus-induced increases in serum IgG1 and IgE levels, the expansion of mesenteric lymph node (MLN) germinal centers, in situ CD4+ T cell expansion, elevated blood eosinophils, and increased intestinal mucosal mast cells. Similarly, both Abs blocked MLN and Peyer's patch cytokine gene expression and elevations in MLN T cell-derived IL-4 protein secretion. However, in the same experiments, administration of either anti-B7-1 or anti-B7-2 Abs alone had little effect on any of these parameters. T cell and B cell activation was also blocked by the combination of anti-B7-2 and a B7-1-specific mutant Y100F CTLA-4Ig construct. These results suggest that to the extent that anti-B7-1 and anti-B7-2 mAbs block B7 interactions, either B7-1 or B7-2 ligand interactions can provide the required costimulatory signals that lead to T cell effector function during a type 2 in vivo immune response.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
158
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4088-96
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9126967-Animals, pubmed-meshheading:9126967-Antibodies, Monoclonal, pubmed-meshheading:9126967-Antigens, CD, pubmed-meshheading:9126967-Antigens, CD80, pubmed-meshheading:9126967-Antigens, CD86, pubmed-meshheading:9126967-B-Lymphocytes, pubmed-meshheading:9126967-Cell Differentiation, pubmed-meshheading:9126967-Cytokines, pubmed-meshheading:9126967-Eosinophils, pubmed-meshheading:9126967-Female, pubmed-meshheading:9126967-Gene Expression, pubmed-meshheading:9126967-Germinal Center, pubmed-meshheading:9126967-Immunity, Mucosal, pubmed-meshheading:9126967-Interleukin-4, pubmed-meshheading:9126967-Lymphocyte Activation, pubmed-meshheading:9126967-Mast Cells, pubmed-meshheading:9126967-Membrane Glycoproteins, pubmed-meshheading:9126967-Mice, pubmed-meshheading:9126967-Mice, Inbred BALB C, pubmed-meshheading:9126967-Nematospiroides dubius, pubmed-meshheading:9126967-Th2 Cells
pubmed:year
1997
pubmed:articleTitle
Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response.
pubmed:affiliation
Department of Microbiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.